Telomere length in Hepatitis C

Cancer Genetics and Cytogenetics

Volumn 187, Issue 1, 2008, Pages 34-38

  Kitay Cohen, Y ^a,c   Goldberg Bittman, L ^a,b   Hadary, R ^a,c   Fejgin, M D ^a,c   Amiel, A ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELL CYCLE; CHROMOSOME SIZE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEPATITIS C; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; PRIORITY JOURNAL; REMISSION; TELOMERE;

ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; DNA; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOCYTES; MALE; MIDDLE AGED; REFERENCE VALUES; TELOMERE;

HEPATITIS C VIRUS;

EID: 55049090026     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.08.006     Document Type: Article

References (26)

1. Harley C.B., Futcher A.B., and Greider C.W. Telomeres shorten during aging of human fibroblasts. Nature 345 (1990) 458-460
2. Allsopp R.C., Vaziri H., Patterson C., Goldstein S., Younglai E.V., Futcher A.B., Greider C.W., and Harley C.B. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89 (1992) 10114-10118
3. Counter C.M., Avilion A.A., LeFeuvre C.E., Stewart N.G., Greider C.W., Harley C.B., and Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11 (1992) 1921-1929
4. Greider C.W. Mammalian telomere dynamics: healing, fragmentation shortening and stabilization. Curr Opin Genet Dev 4 (1994) 203-211
5. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., and Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 266 (1994) 2011-2015
6. Shay J.W., and Bacchetti S.A. A survey to telomerase activity in human cancer. Eur J Cancer 33 (1997) 787-791
7. de Lange T., Shiue L., Myers R.M., Cox D.R., Naylor S.L., Killery A.M., and Varmus H.E. Structure and variability of human chromosome ends. Mol Cell Biol 10 (1990) 518-527
8. Dynek J.N., and Smith S. Resolution of sister telomere association is required for progression through mitosis. Science 304 (2004) 97-100
9. Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., and Greider C.W. Telomere shortening and tumor formation by mouse cells lacking telomerase. RNA 91 (1997) 25-34
10. Rudolph K.L., Chang S., Lee H.W., Blasco M., Gottlieb G.J., Greider C., and DePinho R.A. Longevity, stress response and cancer in aging telomerase-deficient mice. Cell 96 (1999) 701-712
11. Pathak S., and Multani A.S. Aneuploidy, stem cells and cancer. EXS 96 (2006) 49-64
12. Monteverde A., Rivano M.T., Allegra G.C., Monteverde A.I., Zigrossi P., Baglioni P., Gobbi M., Falini B., Bordin G., and Pileri S. Essential mixed cryoglobulinemia type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections. Acta Haematol 79 (1988) 20-25
13. Coleman W.B. Mechanisms of human hepatocarcinogenesis. Curr Mol Med 3 (2003) 573-588
14. Turner N.C., Dusheiko G., Jones A., and Hepatitis C. B-cell lymphoma. Ann Oncol 14 (2003) 1341-1345
15. Sekoguchi S., Nakajima T., Moriguchi M., Jo M., Nishikawa T., Katagishi T., Kimura H., Minami M., Itoh Y., Kagawa K., Tani Y., and Okanoue T. Role of cell-cycle turnover and oxidative stress in telomere shortening and cellular senescence in patients with chronic hepatitis C. J Gastroenterol Hepatol 22 (2007) 182-190
16. Mise K., Tashiro S., Yogita S., Wada D., Harada M., Fukuda Y., Miyake H., Isikawa M., and Izumi K. Sano N.Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinico-pathological factors and prognosis. Clin Cancer Res 4 (1998) 1475-1482
17. Amiel A., Yukla M., Gaber E., Josef G., Fejgin M., and Lishner M. Random aneuploidy in CML patients treated with imatinib. Cancer Genet Cytogenet 168 (2006) 120-123
18. Satra M., Dalekos G.N., Kollia P., Vamvakopoulos N., and Txezou A. Telomerase reverse transcriptase mRNA expression in peripheral lymphocytes of patients with chronic HBV and HCV infections. J Viral Hepatitis 12 (2005) 488-493
19. Tokita H., Fukui H., Tanaka A., Kamitsukasa H., Yagura M., Harada H., and Okamoto H. Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy. J Gastroenterol Hepatol 20 (2005) 752-758
20. Chavalitdhamrong D., and Tanwandee T. Long-term outcomes of chronic hepatitis C patients with sustained virological response at 6 months after the end of treatment. World J Gastroenterol 12 (2006) 5532-5535
21. Tanaka A., Uegaki S., Kurihara H., Aida K., Mikami M., Nagashima I., Shiga J., and Takikawa H. Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C. World J Gastroenterol 13 (2007) 5180-5187
22. Goldberg-Bittman L., Kitay-Cohen Y., Hadary R., Yukla M., Fejgin M.D., and Amiel A. Random aneuploidy in chronic hepatitis C patients and in remission. Cancer Genet Cytogenet 184 (2008) 105-108
23. Amiel A., Goldzak G., Gaber E., Yosef G., Fejgin M.D., Yukla M., and Lishner M. Random aneuploidy and telomere capture in chronic lymphocytic leukemia and chronic myeloid leukemia patients. Cancer Genet Cytogenet 163 (2005) 12-16
24. Amiel A., Gronich N., Yukla M., Suliman S., Josef G., Gaber E., Drori G., Fejgin M.D., and Lishner M. Random aneuploidy in neoplastic and preneoplastic diseases, multiple myeloma, and monoclonal gammopathy. Cancer Genet Cytogenet 162 (2005) 78-81
25. Amiel A., Elis A., Blumenthal D., Gaber E., Fejgin M.D., Dubinsky R., and Lishner M. Modified order of allelic replication in lymphoma patients at different disease stages. Cancer Genet Cytogenet 125 (2001) 156-160
26. Amiel A., Kitay-Cohen Y., Fejgin M.D., and Lishner M. Replication status as a marker for predisposition for lymphoma in patients with chronic hepatitis C with and without cryoglobulinemia. Exp Hematol 28 (2000) 156-160